Shilpa Medicare FY26 Annual Report & AGM Notice Released

Shilpa Medicare Limited has released its Annual Report for the Financial Year 2025-26, coinciding with the notice for its 39th Annual General Meeting (AGM). The AGM is scheduled for Friday, September 11, 2026, at 11:00 AM IST, to be held via Video Conferencing (VC)/Other Audio-Visual Means (OAVM). The report details the company's performance across its key segments including Active Pharmaceutical Ingredients (API), Finished Dosage Formulations, Biologics, and Contract Development and Manufacturing Organisation (CDMO). Significant highlights include the expansion of the API portfolio with 15+ new oncology APIs and the receipt of a Certificate of Suitability (CEP) from EDQM for Methotrexate. The Formulations business saw the commercial launch of a first-in-class novel therapy. The report is available on the company's website.